OCUL

Ocular Therapeutix, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$6.28

Price (1 Year)

$14.56 $6.28

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %4.9 / %30
Non-compliant assets / Total market cap %33.7 / %30
Non-compliant revenue / Total income %30.7 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis.

Website

Analysis (Turkish): OCUL Hissesi Caiz mi, Helal mi? Ocular Therapeutix, Inc. Katılım Analizi